Pharmerica (PMC) Tops Q4 EPS by 2c

Pharmerica (NYSE: PMC) reported Q4 EPS of $0.45, $0.02 better than the analyst estimate of $0.43. Revenue for the quarter came in at $523.5 million versus the consensus estimate of $491.99 million.

For earnings history and earnings-related data on Pharmerica (PMC) click here.

You May Also Be Interested In

• SanDisk upgraded at JPMorgan after investor day; shares climb
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M